CN[C@H]1CCc2cc(OC)c(OC)c(OC)c2-c2ccc(N[C@@H]3CCCCNC3=O)c(=O)cc21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?